Neuromodulation Review 2 (305)

11:15 AM–12:15 PM Saturday, February 29

With the fact that chronic pain afflicts more than 100 million Americans and amid the current opioid crisis, there is great unmet need for innovative alternatives for the treatment of chronic pain.

This session will report on a multicenter, prospective, randomized, double-blind study of this novel SCS system and will also focus on the value of ECAP monitoring to understand the mechanism of action of SCS as well provide neurophysiologic monitoring of spinal cord function.

Advances in using SCS for the management of cancer-related pain with emphasis on recognizing and mitigating possible complications will also be addressed.

Outcomes of Clinical Trials of SCS using ECAPS to Provide Closed-Loop Control

Nagy Mekhail, MD PhD

ECAPS for Neuro-Monitoring

Steven Falowski, MD

Advances in the Use of Spinal Cord Stimulation in the Treatment of Cancer-Related Pain

Lisa Stearns, MD

Learning Objectives:

  • Review the shortfalls of the current ‘fixed output' spinal cord stimulation technology.
  • Appraise the value of measuring the Evoked Compound Action Potential ‘ECAP’ as indicator/monitor of spinal cord activation.
  • Discuss the value and long-term outcomes of spinal cord stimulation for cancer-related pain.